Hubei, China

Hang Ke

This inventor holds 1 USPTO granted patent. Top assignee: Hanx Biopharmaceutics, Inc. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hang Ke. Retrieved from https://idiyas.com/inventor/hang-ke

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Hang Ke

Introduction

Hang Ke is a notable inventor based in Hubei, China. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. His work focuses on innovative solutions for treating serious health conditions.

Latest Patents

Hang Ke holds a patent for an "Anti-OX40 monoclonal antibody and application thereof." This invention includes an anti-OX40 monoclonal antibody or an antigen-binding fragment, along with a corresponding isolated polynucleotide, expression vector, recombinant cell, and pharmaceutical composition. The antibody is designed for use in the treatment of cancer or autoimmune diseases, showcasing its potential impact on medical therapies.

Career Highlights

Hang Ke is associated with Hanx Biopharmaceutics, Inc., where he continues to advance his research and development efforts. His work at the company emphasizes the importance of innovative biopharmaceutical solutions in addressing complex health challenges.

Collaborations

Hang Ke collaborates with Faming Zhang, a talented woman in the field, contributing to the advancement of their shared research goals.

Conclusion

Hang Ke's innovative work in developing therapeutic antibodies positions him as a key figure in biotechnology. His contributions have the potential to significantly impact the treatment of cancer and autoimmune diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…